NPPA notified regarding the fixation of the

Oct 03, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific Compliance The National Pharmaceutical Pricing Authority (NPPA) on October 01, 2024, notified regarding the fixation of the retail price of Gliclazide (in Modified release form) IP 30mg + Metformin (in extended-release form) IP 500mg.

The following has been stated namely: -

• It has fixed the rate at Rs. 7.46/- for the Composition of each uncoated bilayered tablet Containing: Gliclazide (in Modified release form) IP 30mg + Metformin (in extended-release form) IP 500mg.

[Notification no. - 19(4219)/2024/DP/NPPA/DIV.II]

View Document 1